Stryker Rejuvenate and ABG II Hip Implant
The AAJ Stryker Rejuvenate and ABG II Hip Implant Litigation Group will address the issues surrounding the latest hip replacement systems recall. July 6, 2012, Stryker issued a voluntary recall of its Rejuvenate and ABG II modular-neck stems in the United States. This follows the May 2012 Canadian instruction for use recall. Released in early 2010, the Stryker Rejuvenate hip system became one of the company's best-selling joint replacement products. Recently post-market surveillance data and over 40 adverse events reported to the FDA demonstrate the risks associated with fretting and corrosion at the modular neck junction and provide evidence of toxic metal debris loosening and entering the bloodstream. Patients with defective systems suffer pain, inflammation, swelling, tissue damage, and even metallosis. The Stryker Rejuvenate and ABG II Hip Implant Litigation Group member benefits include a Group Document Library, list server, and education programs.
This Litigation Group was formed in July 2012.